PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
ANTINEOPLASTIC ANTIMETABOLITES IMMUNOSUPPRESSIVE AGENTS RAPIDLY DEPHOSPHORYLATED INTO FLUDARABINE AND THEN PHOSPHORYLATED BY DEOXYCYTIDINE KINASE TO THE ACTIVE TRIPHOSPHATE
INJECTION ORAL
DNA POLYMERASE ALPHA, GAMMA AND DELTA RIBONUCLEOTIDE DIPHOSPHATE REDUCTASE DNA PRIMASE DNA LIGASE I
DNA polymerase alpha catalytic subunit UNIPROT P09884 POLA1
PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)
Primary Target and PDB code of Protein-Drug complex
ANTINEOPLASTIC ANTIMETABOLITES IMMUNOSUPPRESSIVE AGENTS FLUDARABINE PHOSPHATE IS RAPIDLY DEPHOSPHORYLATED AND THEN PHOSPHORYLATED BY DEOXYCYTIDINE KINASE TO THE ACTIVE TRIPHOSPHATE
-
DNA POLYMERASE ALPHA, GAMMA AND DELTA RIBONUCLEOTIDE DIPHOSPHATE REDUCTASE DNA PRIMASE DNA LIGASE I
PDB6DWK (SAMHD1 BOUND TO FLUDARABINE-TP IN THE CATALYTIC POCKET)